| __timestamp | CRISPR Therapeutics AG | Sarepta Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 5114000 | 49315000 |
| Thursday, January 1, 2015 | 13403000 | 75043000 |
| Friday, January 1, 2016 | 31056000 | 83749000 |
| Sunday, January 1, 2017 | 35845000 | 122682000 |
| Monday, January 1, 2018 | 48294000 | 207761000 |
| Tuesday, January 1, 2019 | 63488000 | 284812000 |
| Wednesday, January 1, 2020 | 88208000 | 317875000 |
| Friday, January 1, 2021 | 102802000 | 282660000 |
| Saturday, January 1, 2022 | 102464000 | 451421000 |
| Sunday, January 1, 2023 | 76162000 | 481871000 |
| Monday, January 1, 2024 | 72977000 |
Unlocking the unknown
In the dynamic world of biotechnology, understanding a company's operational efficiency is crucial. This analysis compares the Selling, General, and Administrative (SG&A) expenses of two pioneering firms: Sarepta Therapeutics, Inc. and CRISPR Therapeutics AG, from 2014 to 2023. Over this period, Sarepta consistently outspent CRISPR, with its SG&A expenses peaking at nearly 482 million in 2023, a staggering 530% increase from 2014. In contrast, CRISPR's expenses grew by approximately 1,390%, reaching 76 million in 2023. This disparity highlights Sarepta's aggressive investment in administrative functions, possibly reflecting its expansive growth strategy. Meanwhile, CRISPR's leaner approach may indicate a focus on innovation and cost efficiency. As the biotech landscape evolves, these financial strategies could significantly impact each company's market positioning and long-term success.
Who Optimizes SG&A Costs Better? Zoetis Inc. or Sarepta Therapeutics, Inc.
Comparing SG&A Expenses: Takeda Pharmaceutical Company Limited vs Sarepta Therapeutics, Inc. Trends and Insights
Cost Management Insights: SG&A Expenses for Teva Pharmaceutical Industries Limited and CRISPR Therapeutics AG
Who Optimizes SG&A Costs Better? Viatris Inc. or CRISPR Therapeutics AG
Sarepta Therapeutics, Inc. vs Walgreens Boots Alliance, Inc.: SG&A Expense Trends
Sarepta Therapeutics, Inc. or MorphoSys AG: Who Manages SG&A Costs Better?
Who Optimizes SG&A Costs Better? Sarepta Therapeutics, Inc. or Evotec SE
Operational Costs Compared: SG&A Analysis of Opthea Limited and CRISPR Therapeutics AG
CRISPR Therapeutics AG and Bausch Health Companies Inc.: SG&A Spending Patterns Compared
CRISPR Therapeutics AG or HUTCHMED (China) Limited: Who Manages SG&A Costs Better?
CRISPR Therapeutics AG or Soleno Therapeutics, Inc.: Who Manages SG&A Costs Better?
Operational Costs Compared: SG&A Analysis of CRISPR Therapeutics AG and Viridian Therapeutics, Inc.